Annual Total Expenses
$38.65 B
-$1.14 B-2.88%
31 December 2023
Summary:
AstraZeneca annual total expenses is currently $38.65 billion, with the most recent change of -$1.14 billion (-2.88%) on 31 December 2023. During the last 3 years, it has risen by +$15.95 billion (+70.24%). AZN annual total expenses is now -2.88% below its all-time high of $39.79 billion, reached on 31 December 2022.AZN Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$11.46 B
+$1.27 B+12.43%
30 September 2024
Summary:
AstraZeneca quarterly total expenses is currently $11.46 billion, with the most recent change of +$1.27 billion (+12.43%) on 30 September 2024. Over the past year, it has increased by +$1.92 billion (+20.14%). AZN quarterly total expenses is now -15.11% below its all-time high of $13.50 billion, reached on 31 December 2021.AZN Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.9% | +20.1% |
| 3 y3 years | +70.2% | -0.7% |
| 5 y5 years | +79.1% | +102.8% |
AZN Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.9% | +70.2% | -15.1% | +33.7% |
| 5 y | 5 years | -2.9% | +79.1% | -15.1% | +129.6% |
| alltime | all time | -2.9% | +659.3% | -15.1% | +776.1% |
AstraZeneca Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $11.46 B(+12.4%) |
| June 2024 | - | $10.19 B(+6.6%) |
| Mar 2024 | - | $9.56 B(+3.6%) |
| Dec 2023 | $38.65 B(-2.9%) | $9.23 B(-3.2%) |
| Sept 2023 | - | $9.54 B(+6.5%) |
| June 2023 | - | $8.96 B(+4.5%) |
| Mar 2023 | - | $8.57 B(-7.8%) |
| Dec 2022 | $39.79 B(+6.0%) | $9.30 B(-4.5%) |
| Sept 2022 | - | $9.74 B(-4.8%) |
| June 2022 | - | $10.23 B(-2.7%) |
| Mar 2022 | - | $10.51 B(-22.1%) |
| Dec 2021 | $37.55 B(+65.4%) | $13.50 B(+17.0%) |
| Sept 2021 | - | $11.54 B(+62.7%) |
| June 2021 | - | $7.09 B(+30.7%) |
| Mar 2021 | - | $5.42 B(-24.3%) |
| Dec 2020 | $22.70 B(+0.2%) | $7.17 B(+32.6%) |
| Sept 2020 | - | $5.41 B(+8.3%) |
| June 2020 | - | $4.99 B(-2.8%) |
| Mar 2020 | - | $5.13 B(-29.4%) |
| Dec 2019 | $22.65 B(+5.0%) | $7.27 B(+28.7%) |
| Sept 2019 | - | $5.65 B(+6.0%) |
| June 2019 | - | $5.33 B(+21.3%) |
| Mar 2019 | - | $4.39 B(-47.7%) |
| Dec 2018 | $21.57 B(+5.7%) | $8.40 B(+89.9%) |
| Sept 2018 | - | $4.43 B(+0.8%) |
| June 2018 | - | $4.39 B(-2.0%) |
| Mar 2018 | - | $4.48 B(-33.3%) |
| Dec 2017 | $20.41 B(+5.1%) | $6.72 B(+32.1%) |
| Sept 2017 | - | $5.08 B(+23.2%) |
| June 2017 | - | $4.13 B(-8.1%) |
| Mar 2017 | - | $4.49 B(+2.4%) |
| Dec 2016 | $19.43 B(-10.2%) | $4.38 B(-6.2%) |
| Sept 2016 | - | $4.67 B(-11.9%) |
| June 2016 | - | $5.30 B(+4.4%) |
| Mar 2016 | - | $5.08 B(-20.1%) |
| Dec 2015 | $21.64 B(-10.4%) | $6.36 B(+33.2%) |
| Sept 2015 | - | $4.78 B(-11.3%) |
| June 2015 | - | $5.38 B(+5.1%) |
| Mar 2015 | - | $5.12 B(-24.8%) |
| Dec 2014 | $24.16 B(+9.3%) | $6.81 B(+12.3%) |
| Sept 2014 | - | $6.07 B(+7.3%) |
| June 2014 | - | $5.65 B(+0.5%) |
| Mar 2014 | - | $5.62 B(-25.4%) |
| Dec 2013 | $22.11 B(+10.1%) | $7.54 B(+66.0%) |
| Sept 2013 | - | $4.54 B(-9.7%) |
| June 2013 | - | $5.03 B(+0.9%) |
| Mar 2013 | - | $4.99 B(-10.6%) |
| Dec 2012 | $20.09 B(-10.0%) | $5.58 B(+23.3%) |
| Sept 2012 | - | $4.53 B(-5.6%) |
| June 2012 | - | $4.79 B(-7.7%) |
| Mar 2012 | - | $5.19 B(-35.2%) |
| Dec 2011 | $22.31 B(+2.7%) | $8.01 B(+102.6%) |
| Sept 2011 | - | $3.95 B(-27.7%) |
| June 2011 | - | $5.46 B(+11.7%) |
| Mar 2011 | - | $4.89 B(-20.4%) |
| Dec 2010 | $21.72 B | $6.15 B(+11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $5.49 B(+6.8%) |
| June 2010 | - | $5.14 B(+4.3%) |
| Mar 2010 | - | $4.93 B(-31.2%) |
| Dec 2009 | $21.81 B(-2.9%) | $7.17 B(+43.6%) |
| Sept 2009 | - | $5.00 B(-2.2%) |
| June 2009 | - | $5.11 B(+12.5%) |
| Mar 2009 | - | $4.54 B(-30.8%) |
| Dec 2008 | $22.46 B(+4.6%) | $6.56 B(+25.1%) |
| Sept 2008 | - | $5.24 B(-2.0%) |
| June 2008 | - | $5.35 B(+0.9%) |
| Mar 2008 | - | $5.30 B(-22.5%) |
| Dec 2007 | $21.46 B(+17.6%) | $6.84 B(+37.4%) |
| Sept 2007 | - | $4.98 B(+1.2%) |
| June 2007 | - | $4.92 B(+4.5%) |
| Mar 2007 | - | $4.71 B(-8.5%) |
| Dec 2006 | $18.26 B(+4.6%) | $5.15 B(+16.8%) |
| Sept 2006 | - | $4.41 B(-1.9%) |
| June 2006 | - | $4.49 B(+6.9%) |
| Mar 2006 | - | $4.20 B(-9.6%) |
| Dec 2005 | $17.45 B(+3.4%) | $4.65 B(+13.6%) |
| Sept 2005 | - | $4.09 B(-7.2%) |
| June 2005 | - | $4.41 B(+2.9%) |
| Mar 2005 | - | $4.29 B(-5.3%) |
| Dec 2004 | $16.88 B(+13.7%) | $4.53 B(+10.6%) |
| Sept 2004 | - | $4.09 B(-3.4%) |
| June 2004 | - | $4.24 B(+5.3%) |
| Mar 2004 | - | $4.02 B(-2.6%) |
| Dec 2003 | $14.84 B(+7.3%) | $4.13 B(+12.2%) |
| Sept 2003 | - | $3.68 B(+3.4%) |
| June 2003 | - | $3.56 B(+2.7%) |
| Mar 2003 | - | $3.47 B(-13.0%) |
| Dec 2002 | $13.84 B(+12.3%) | $3.99 B(+12.2%) |
| Sept 2002 | - | $3.55 B(+9.4%) |
| June 2002 | - | $3.25 B(+6.5%) |
| Mar 2002 | - | $3.05 B(-9.0%) |
| Dec 2001 | $12.32 B(-9.7%) | $3.35 B(+14.1%) |
| Sept 2001 | - | $2.94 B(-7.1%) |
| June 2001 | - | $3.16 B(+7.0%) |
| Mar 2001 | - | $2.95 B(-38.4%) |
| Dec 2000 | $13.64 B(+16.6%) | $4.79 B(+67.7%) |
| Sept 2000 | - | $2.86 B(-4.9%) |
| June 2000 | - | $3.00 B(+0.2%) |
| Mar 2000 | - | $3.00 B(+129.0%) |
| Dec 1999 | $11.70 B(+31.6%) | $1.31 B(-61.2%) |
| Sept 1999 | - | $3.37 B(-4.0%) |
| June 1999 | - | $3.51 B(+40.2%) |
| Dec 1998 | $8.89 B(+31.2%) | - |
| June 1998 | - | $2.51 B(+52.9%) |
| Dec 1997 | $6.77 B(-7.4%) | - |
| Dec 1996 | $7.32 B(+24.3%) | - |
| Dec 1995 | $5.89 B(+1.3%) | - |
| June 1995 | - | $1.64 B |
| Dec 1994 | $5.81 B(+4.7%) | - |
| Dec 1993 | $5.55 B(+9.0%) | - |
| Dec 1992 | $5.09 B(-16.3%) | - |
| Dec 1991 | $6.08 B(+0.7%) | - |
| Dec 1990 | $6.04 B | - |
FAQ
- What is AstraZeneca annual total expenses?
- What is the all time high annual total expenses for AstraZeneca?
- What is AstraZeneca annual total expenses year-on-year change?
- What is AstraZeneca quarterly total expenses?
- What is the all time high quarterly total expenses for AstraZeneca?
- What is AstraZeneca quarterly total expenses year-on-year change?
What is AstraZeneca annual total expenses?
The current annual total expenses of AZN is $38.65 B
What is the all time high annual total expenses for AstraZeneca?
AstraZeneca all-time high annual total expenses is $39.79 B
What is AstraZeneca annual total expenses year-on-year change?
Over the past year, AZN annual total expenses has changed by -$1.14 B (-2.88%)
What is AstraZeneca quarterly total expenses?
The current quarterly total expenses of AZN is $11.46 B
What is the all time high quarterly total expenses for AstraZeneca?
AstraZeneca all-time high quarterly total expenses is $13.50 B
What is AstraZeneca quarterly total expenses year-on-year change?
Over the past year, AZN quarterly total expenses has changed by +$1.92 B (+20.14%)